ITOS insider buying – iTeos Therapeutics, Inc.

8 insider purchases since 2016 worth $76.7M by 6 different insiders. Last 12 months: 0 purchases, $0. Most recent filing: 2025-05-16.

Where insiders bought and sold ITOS – last 5 yearsCEO / officers Directors Funds & 10% owners Sales

Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits. 3 older purchases (before the 5-year window) are listed in the table below.

Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.

Bought, sold, still holding?

InsiderBoughtFirst / last buySold since 2016Holds now*Status
EcoR1 Capital, LLC
10% Owner
$38.7M
1× · 4,958,978 sh
2025-05-14
2025-05-14
–7,388,978 shares
as of 2025-05-16
Holds - never sold
Boxer Asset Management Inc.
10% Owner
$27.1M
1× · 1,425,000 sh
2020-07-28
2020-07-28
–48,691 shares
as of 2020-07-29
Holds - never sold
MPM Oncology Impact Management GP LLC
Director
$6.1M
1× · 320,000 sh
2020-07-28
2020-07-28
–25,974 shares
as of 2020-07-30
Holds - never sold
MPM BioVentures 2014 GP LLC
10% Owner
$3.0M
1× · 160,000 sh
2020-07-28
2020-07-28
–1,993,932 shares
as of 2020-07-29
Holds - never sold
Davis Aaron I.
Director
$1.6M
1× · 50,000 sh
2022-03-22
2022-03-22
3× · $29.9M
last 2023-08-23
2,946,915 shares
as of 2024-05-14
Sold part
Gall Matthew
CFO
$210,950
3× · 15,000 sh
2021-06-16
2024-11-19
1× · $232,250
last 2021-12-27
0 shares
as of 2025-08-29
Sold everything

* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.

Insider buying and selling by year

YearPurchasesBoughtBuyersSalesSold
20251$38.7M15$17.2M
20241$38,6501––
20231$41,85011$5.7M
20221$1.6M117$97.7M
20211$130,450150$71.0M
20203$36.2M3––

Insider purchases

FiledInsiderRoleSharesAvg priceValueHoldingsFiling
2025-05-16EcoR1 Capital, LLC10% Owner4,958,978$7.80$38.7M+86.5%SEC
2024-11-19Gall MatthewCFO5,000$7.73$38,650+8.3%SEC
2023-10-12Gall MatthewCFO5,000$8.37$41,850+34.7%SEC
2022-03-24Davis Aaron I.Director50,000$32.51$1.6M+1.6%SEC
2021-06-16Gall MatthewCFO5,000$26.09$130,450SEC
2020-07-30MPM Oncology Impact Management GP LLCDirector320,000$19.00$6.1M+15.7%SEC
2020-07-29MPM BioVentures 2014 GP LLC10% Owner160,000$19.00$3.0M+8.3%SEC
2020-07-29Boxer Asset Management Inc.10% Owner1,425,000$19.00$27.1M+48.8%SEC

Insider sales

FiledInsiderRoleSharesAvg priceValueTypeFiling
2025-06-11Detheux MichelCEO104,565$10.03$1.0MSaleSEC
2025-06-06Hallal DavidDirector114,682$10.15$1.2MSaleSEC
2025-06-06Detheux MichelCEO156,847$10.15$1.6MSaleSEC
2025-05-15MPM BioImpact LLCOther1,031,931$8.06$8.3MSaleSEC
2025-05-15MPM BIOVENTURES 2018 (B), L.P.Other630,191$8.06$5.1MSaleSEC
2023-08-25Davis Aaron I.Other350,000$16.26$5.7MSaleSEC
2022-06-10Hallal DavidDirector29,615$20.17$597,214SaleSEC
2022-05-11Davis Aaron I.Director663,000$21.04$14.0MSaleSEC
2022-05-02Davis Aaron I.Director375,000$27.32$10.2MSaleSEC
2022-04-19Detheux MichelCEO11,500$31.87$366,530SaleSEC
2022-03-22Detheux MichelCEO18,437$34.17$629,987SaleSEC
2022-03-18Boxer Capital, LLC10% Owner575,201$35.25$20.3MSaleSEC
2022-03-14Lager Joanne JenkinsOfficer3,500$36.01$126,035SaleSEC
2022-03-02McGrath YvonneOfficer10,000$36.76$367,600SaleSEC
2022-02-24Detheux MichelCEO14,500$34.34$497,905SaleSEC

Showing the latest 15 of 73 sales of $50,000+ since 2016.

Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.

Get every new insider purchase the day it's filed

Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.

Get started free